Vori Health Secures $53 Million in Series B Funding to Transform Value-Based Musculoskeletal Care

Vori Health, the nation’s pioneering physician-led solution for musculoskeletal care, is making waves in the healthcare industry and just announced a $53 million Series B funding round. Led by NEA and with continued support from AlleyCorp, Intermountain Health’s Intermountain Ventures, Echo Health Ventures, and Max Ventures, this heavily oversubscribed round is a testament to Vori Health’s rapid growth and innovative care model. In just 18 months, the company has delivered remarkable clinical outcomes and significant cost savings for patients and partners alike, while achieving an 800% revenue increase.

Founded to revolutionize the U.S. musculoskeletal care system in which patients often endure fragmented treatment paths, unnecessary surgeries, and subpar outcomes at premium costs, Vori Health’s comprehensive physician-led approach has achieved extraordinary milestones since its Series A funding. These transformative results include 91.6% of patients reporting clinically significant pain improvement, a remarkable 78-90% reduction in elective orthopedic surgeries, a 42% decrease in opioid utilization, and up to a 68% reduction in depression and anxiety among patients.

With these groundbreaking outcomes driving investor confidence, Dr. Ryan Grant, Co-Founder and CEO of Vori Health, sees the new funding as confirmation of the company’s vision. “This investment marks a pivotal moment in our journey to deliver truly value-based musculoskeletal care at scale,” stated Dr. Grant. “By integrating board-certified specialty physicians, cohesive care teams, and cutting-edge technology, we’re achieving outstanding outcomes nationwide. The swift adoption of our platform by Fortune 200 companies and national health plans clearly indicates that the market is primed for our comprehensive solutions.”

“Vori Health’s physician-led model, combined with exceptional clinical results and improved cost savings, distinguishes them in a highly competitive market,” said Mohamad Makhzoumi, Co-CEO, NEA. “We believe Vori has emerged as a pioneering leader in the value-based musculoskeletal care space and are thrilled to deepen our partnership as they continue to scale their transformative value-based care delivery platform.”

By delivering a verified 4:1 ROI while maintaining exceptional patient satisfaction, Vori Health’s integrated approach strongly appeals to health plan and employer clients. “With musculoskeletal conditions representing a large part of our healthcare spend, partnering with an innovative leader like Vori Health has been one of our best strategic decisions,” said the Vice President of Medical Affairs at a large health plan partner. “Their physician-led approach delivers exceptional care in a convenient setting that our members value while generating substantial cost savings for our organization—it’s the win-win solution we’ve been searching for.”

The new funding will propel Vori Health’s mission to transform value-based musculoskeletal care across the nation. Plans include deepening its value-based care initiatives (including evolving toward increasingly sophisticated economic models with two-sided population health risk), investing in advanced data analytics for more precise targeting of high-risk members, and enhancing its AI-powered technology platform and clinical programs to benefit even more patients, employers, and health plan partners.

This capital infusion empowers Vori Health to accelerate its vision of a healthcare system in which musculoskeletal treatment is not only more effective and accessible, but fundamentally more humane—offering patients a pathway to recovery that optimizes their outcomes, reduces unnecessary interventions, and transforms the overall care experience.